To access this element change to forms mode OFF
Grant Award View - GA294524
Personalising Innate-immunotherapy for Superior Treatment Outcomes with...
GA ID:
GA294524
Agency:
Department of Health and Aged Care
Approval Date:
13-Dec-2022
Publish Date:
11-Apr-2023
Category:
Medical Research
Grant Term:
1-Feb-2023 to 31-Jan-2026
Value (AUD):
$990,020.97
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 22/23 1.1 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
Personalising Innate-immunotherapy for Superior Treatment Outcomes with Large anticancer applicability (PISTOL)
Purpose:
This project will discover mechanisms to maximise tumoricidal functions of a novel off-the-shelf living drug, “Super Killer†NK cells. These cells are designed to detect and kill hard-to-cure metastatic solid cancers to prevent tumour spread and provide a safer therapy option than current treatments. This project will also advance the knowledge of how cancer cells hide from immune cells, which can be leveraged to develop more effective and commercially available immunotherapy interventions.
GO ID:
GO Title:
MRFF - 2021 Early to Mid-Career Researchers Grant Opportunity
Internal Reference ID:
2022/MRF2019485
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The University of Queensland
Recipient ABN:
63 942 912 684
Grant Recipient Location
Suburb:
St Lucia
Town/City:
St Lucia
Postcode:
4072
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
QLD
Postcode:
Country:
AUSTRALIA